Full-Time

Lung Transplant Nurse Coordinator

Pre-Transplant

Updated on 9/9/2026

Deadline 9/19/26
Mass General Brigham

Mass General Brigham

1-10 employees

Early-stage life science venture investor

Compensation Overview

$41.71 - $105.65/hr

+ Differentials + Premiums + Bonuses

Boston, MA, USA

In Person

The role is primarily on campus and may require work at off-site Massachusetts and surrounding-state locations; additional state licensure may be needed.

Bachelor's

Category
Medical, Clinical & Veterinary (1)
Required Skills
Infection Control
Epic (EHR)
Nursing
Patient Education

Get referred to Mass General Brigham

See people who can refer or advise you

Requirements
  • Graduate of an approved school of nursing with current registration in Massachusetts.
  • Bachelor of Science in Nursing degree.
  • At least one year of recent experience within the past two years caring for pulmonary, thoracic surgery, or lung transplant patients.
  • Ability to work independently while collaborating with others in the care of complex patients with advanced lung disease, multiple comorbidities, and eventual lung transplantation.
  • Ability to work on campus wearing appropriate personal protective equipment when caring for patients requiring enhanced precautions.
  • Ability to triage and manage high patient volumes with complex needs.
  • Ability to obtain additional nursing licensure in other states if required for off-site work.
  • Ability to work rotating and variable shifts.
Responsibilities
  • Provide ambulatory and in-hospital care for pre-transplant, inpatient, and post-transplant patients, with a focus on pre-transplant care.
  • Coordinate transitions between pre-transplant, peri-transplant, and post-transplant phases across ambulatory and hospital settings.
  • Collect and enter patient data into Epic and transplant regulatory databases.
  • Review referrals and medical records, identify potential transplant patients, and communicate with referring physician practices.
  • Coordinate pre-transplant evaluations with primary care providers and the multidisciplinary transplant team.
  • Coordinate and facilitate new-patient and pre-transplant clinic sessions and ensure completion of required testing.
  • Participate in informed-consent processes and provide education about transplant risks, benefits, evaluation procedures, immunosuppressive medication risks, and alternatives.
  • Facilitate lung-transplant candidacy evaluations and ensure multidisciplinary participation according to protocols and policies.
  • Compile and summarize evaluation results for multidisciplinary selection committee meetings and document candidacy decisions.
  • Communicate selection committee recommendations to patients and referring physicians.
  • Coordinate patient and family education programs and maintain patient-teaching materials.
  • Coordinate with administrative, financial, social-work, and clinical team members to support patient care.
  • Communicate patient information through documentation, conferences, and transplant-team updates.
  • Conduct post-acute follow-up and coordinate follow-up care, care plans, utilization, and service quality.
  • Maintain systems that communicate patients' current care levels and clinical-status changes to the transplant team, referring physicians, payers, the United Network for Organ Sharing, and other stakeholders.
  • Participate in multidisciplinary conferences, medical-management meetings, quality-assurance and performance-improvement processes, and electronic-care improvement initiatives.
  • Coordinate outpatient care, multidisciplinary rounds, assessment and care-plan documentation, discharge planning, and follow-up.
  • Facilitate communication among physicians, social workers, transplant pharmacists, nutritionists, consultants, inpatient teams, outpatient teams, and nurse practitioners.
  • Assess patients by telephone, monitor treatment response, adjust medications in consultation with clinical providers, and arrange outpatient or inpatient follow-up.
  • Assist with urgent triage, emergency-room visits, and transfers from outside institutions, documenting care provided.
  • Arrange specialty consultations, follow up on recommendations, and communicate results.
  • Coordinate correspondence with patients, employers, pharmacies, insurers, and other providers regarding prescriptions, rehabilitation, disability, leave, and payment coverage.
  • Attend clinical meetings and lung-transplant clinics as needed.
  • Assist patients and families with financial support, insurance coverage, medications, housing, and utilities.
  • Cross-train to cover inpatient and post-lung-transplant nurse coordinators.
  • Collect demographic and clinical data from hospital systems, administrative sources, charts, and conferences and enter it into transplant databases, including the United Network for Organ Sharing system.
  • Provide clinical data to research nurses for enrolled study subjects.
  • Prepare clinical or administrative summaries when requested.
  • Establish professional relationships with healthcare team members, patients, families, and referring providers.
  • Serve as a clinical resource for staff by assisting with care coordination, clinical skills, and patient teaching.
  • Maintain communication with other transplant programs and professional organizations and incorporate new scientific findings into clinical practice.
  • Participate in research activities, staff orientation, policy development, transplant-program goals, and program reviews.
Desired Qualifications
  • Prior experience caring for lung-transplant patients.
  • At least one year of transplant-coordinator experience within the past five years.
  • Recent ambulatory experience with telephone triage, including assessment, management, planning, and execution.
  • Knowledge of community resources and post-acute or non-acute care providers.
  • Familiarity with discharge and resource planning.
  • ABTC Certified Clinical Transplant Coordinator certification.
  • Active membership in a related professional organization.

Mass General Brigham Ventures funds early-stage life science ideas arising from Mass General Brigham’s research network. It provides first access to deal flow and proprietary rights, backing the formation and growth of new companies and technologies. It uses capital and support to help translate bold innovations into drugs and medical technologies that improve patient outcomes worldwide.

Company Size

1-10

Company Stage

N/A

Total Funding

$1.9B

Headquarters

Cambridge, Massachusetts

Founded

2008

Get referred to Mass General Brigham

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • 2025 operating income reached $59 million, with $240 million efficiency savings announced.
  • The January 12, 2026 Tampa General JV opened a Palm Beach Gardens radiation center.
  • August 2026 Network Bio collaboration expands MGB biobank access for AI drug discovery.

What critics are saying

  • April 29, 2026 nurses picketed over 0% raises, closures, and $35.9 million executive pay.
  • July 8, 2026 strike and lockout hit 4,700 nurses; August 11 talks remained stalled.
  • Persistent labor conflict drives temp-nurse dependence, service instability, and brand damage through 2026.

What makes Mass General Brigham unique

  • MGB Ventures gets first access to Mass General and Brigham discoveries across 2008-present.
  • The research network spans premier hospitals, enabling proprietary clinical-deal sourcing.
  • The January 12, 2026 Tampa General JV extends academic-medical brands into Florida outpatient care.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Hybrid Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

401(k) Company Match

Parental Leave

Adoption Assistance

Childcare Support

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Meal Benefits

Commuter Benefits

Legal Services

Employee Discounts

Company Social Events

Company News

Claris Bio
Jul 29th, 2026
07-28-2026 Press Releases from Claris Bio

Latest Press Releases from Claris Bio.

Fierce Healthcare
Jun 15th, 2026
InStride Health lands $30M series C to expand pediatric mental health services

InStride Health, a provider of virtual specialty mental healthcare for children and young adults, has raised $30 million in Series C funding led by Echo Health Ventures and FMZ Ventures. Existing investors including .406 Ventures, General Catalyst and Mass General Brigham Ventures also participated. Founded in 2021, InStride offers insurance-based treatment for anxiety and obsessive-compulsive disorder in patients aged seven to 24. The company pairs each patient with a care team comprising a psychiatrist, therapist and exposure coach, providing support through text and a mobile application. InStride has treated 5,000 patients across 17 states, primarily on the East Coast and Texas. The company published data showing 97% of patients demonstrated clinical improvement, with a 53% average reduction in anxiety scores. The funding will support expansion into new markets and strengthen payer partnerships.

Associated Press
May 13th, 2026
Violet Therapeutics raises $4.75M to advance synaptic preservation therapy for neurodegenerative diseases

Violet Therapeutics, a biotechnology company developing therapies for neurodegenerative diseases, has raised $4.75 million in a seed extension round led by Lifespan Vision Ventures. Dementia Discovery Fund, UTEC, Ono Venture Investment and Mass General Brigham Ventures also participated. The Cambridge-based company will use the funding to advance its lead small molecule programme targeting EphB3 through IND-enabling activities. The therapy aims to halt and potentially reverse cognitive decline through glial-mediated synaptic preservation, addressing synaptic loss, the strongest predictor of cognitive decline in Alzheimer's and other neurodegenerative diseases. Violet's proprietary CONNECT platform maps cell-cell interaction networks to identify novel therapeutic targets. Founded by Mass General Brigham Ventures with researchers from Brigham and Women's Hospital, the company is developing first-in-class CNS therapies.

PR Newswire
Apr 23rd, 2026
Brigham nurses to picket as MGB executives earn $35.9M amid service closures and 0% wage offer

Registered nurses at Brigham and Women's Hospital will hold an informational picket on 29 April, protesting Mass General Brigham's corporate decisions affecting patient care and workforce conditions. The Massachusetts Nurses Association represents the nurses, who will demonstrate from 14:00 to 16:00 outside the hospital at 75 Francis Street, Boston. Nurses cite several service closures under MGB, including the Weiner Centre, Burn Unit and Integrated Care Management Programme. They criticise the health system's bargaining proposals, particularly a 0% wage offer for nurses below top step, whilst MGB reported a $59.2 million operating gain in 2025 and paid its top 14 executives $35.9 million in fiscal year 2024. The informational picket will not disrupt patient care, with nurses participating outside working hours.

PR Newswire
Mar 19th, 2026
MGB Home Care clinicians to picket Mass General over stalled contract talks after year of bargaining

Approximately 450 clinicians at Mass General Brigham Home Care, represented by the Massachusetts Nurses Association, will hold an informational picket on 24 March outside Massachusetts General Hospital. The clinicians are seeking their first union contract after more than 20 bargaining sessions since March 2025. The bargaining unit includes registered nurses, occupational therapists, physical therapists, speech language pathologists, social workers and dieticians who voted to join the MNA in June 2024. They are demanding reasonable caseload limits, clear productivity standards, competitive wages and recruitment protections. MGB reported a $59.2 million operating gain in the year ending September 2025, with CEO Dr Anne Klibanski's compensation rising 40% to $8.4 million in 2024. The picket is scheduled for 15:30 to 17:00 and is not a strike.